Supreme Completes Pre-License Upgrades at Kincardine Greenhouse

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 12, 2014) - Supreme Pharmaceuticals Inc. (the "Company") (OTCBB:SPRWF) (CSE:SL) is pleased to report that the Company has completed the security and infrastructure upgrades at the hybrid industrial greenhouse facility in Kincardine, Ontario (the "Facility") and is ready for the Health Canada pre-license inspection of the Facility.

Since the acquisition of the 342,000 sq. ft. facility in May 2014, the Company has spent approximately $4M in upgrades to transform the Facility from an out-of use tomato greenhouse to a highly secured, state-of-the-art, automated medical marijuana facility. These upgrades include a level 9 security vault capable of storing up to $150 million of dried marijuana, a sophisticated digital security system including intrusion detection and visual surveillance, as well as sanitation and automation, all which meets or exceeds the regulatory requirements set by Health Canada.

The Company and its management team have carefully planned the upgrades of the Facility to provide an optimal environment to manufacture high quality, low-cost medical marijuana. If successful in obtaining the license to produce medical marijuana subsequent to the pre-license inspection, the Company expects to immediately commence growing in its first completed phase of the Facility. Subsequent phases of the Facility are expected to be built out later in 2015 which will increase the productive capacity of the Facility. No date has been set yet for the Health Canada inspection.

John Fowler, the Company's Director of Operations, stated: "The construction thus far has been a massive undertaking for us. We are excited to move forward in the licensing process and stay on track with our goal of providing high-quality, low-cost medical marijuana in the coming months."

FORWARD-LOOKING INFORMATION

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the obtaining of a grow license, as well as the Company's corporate strategy. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company's ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.